QTL: GWAS1132162_H (triglyceride measurement QTL GWAS1132162 (human)) Homo sapiens
Symbol:
GWAS1132162_H
Name:
triglyceride measurement QTL GWAS1132162 (human)
RGD ID:
597036088
Trait:
triglyceride measurement
Measurement Type:
blood triglyceride level (CMO:0000118)
LOD Score:
Not Available
P Value:
5.0E-10
Variance:
Not Available
Position
Human Assembly Chr Position (strand) Source JBrowse GRCh38 15 40,104,990 - 40,104,991 RGD_MAPPER_PIPELINE GRCh38 GRCh37 15 40,397,191 - 40,397,192 RGD_MAPPER_PIPELINE GRCh37
Population Stats:
Not Available
JBrowse:
View Region in Genome Browser (JBrowse)
Model
1342866 BMF Bcl2 modifying factor 15 40087890 40108879 Human 329343660 LOC129663550 ReSE screen-validated silencer GRCh37_chr15:40397101-40397293 15 40104900 40105092 Human
Peak: (rs34245505 )
Human Assembly Chr Position (strand) Source GRCh38 15 40,104,990 - 40,104,991 RGD_MAPPER_PIPELINE
2289410 BW327_H Body weight QTL 327 (human) 3.32 0.0001 Body fat amount 15 19980129 45980129 Human 1559411 SCL107_H Serum cholesterol level QTL 107 (human) 3.88 Lipid level triglyceride 15 26543552 52543552 Human 597346366 GWAS1442440_H FEV/FVC ratio QTL GWAS1442440 (human) 1e-15 FEV/FVC ratio forced expiratory volume to forced vital capacity ratio (CMO:0000241) 15 40104990 40104991 Human 407054315 GWAS703291_H vital capacity QTL GWAS703291 (human) 2e-12 vital capacity 15 40104990 40104991 Human 597060543 GWAS1156617_H FEV/FVC ratio QTL GWAS1156617 (human) 5e-19 FEV/FVC ratio forced expiratory volume to forced vital capacity ratio (CMO:0000241) 15 40104990 40104991 Human 597302992 GWAS1399066_H BMI-adjusted hip circumference QTL GWAS1399066 (human) 4e-11 BMI-adjusted hip circumference hip circumference (CMO:0000014) 15 40104990 40104991 Human 1559354 LDLPS4_H Low density lipoprotein particle size QTL 4 (human) 2.2 0.019 LDL particle size 15 34790230 60790230 Human 597321591 GWAS1417665_H triglyceride measurement QTL GWAS1417665 (human) 6e-10 triglyceride measurement blood triglyceride level (CMO:0000118) 15 40104990 40104991 Human 2289420 BW314_H Body weight QTL 314 (human) 2.72 0.0003 Body weight lean mass 15 19980129 45980129 Human 597036088 GWAS1132162_H triglyceride measurement QTL GWAS1132162 (human) 5e-10 triglyceride measurement blood triglyceride level (CMO:0000118) 15 40104990 40104991 Human 1643273 BW330_H Body Weight QTL 330 (human) 1.05 0.014 Body weight body mass index 15 26866719 52866719 Human 2289430 BMD7_H Bone mineral density QTL 7 (human) 3.32 0.0001 Bone mineral density 15 19980129 45980129 Human 2299958 PRSTS330_H Prostate tumor susceptibility QTL 330 (human) 1.02 0.0151 Prostate tumor susceptibility 15 34790230 60790230 Human 407104308 GWAS753284_H FEV/FVC ratio QTL GWAS753284 (human) 7e-13 FEV/FVC ratio forced expiratory volume to forced vital capacity ratio (CMO:0000241) 15 40104990 40104991 Human 597605097 GWAS1661957_H type 2 diabetes mellitus QTL GWAS1661957 (human) 3e-20 type 2 diabetes mellitus 15 40104990 40104991 Human 1643523 BW284_H Body Weight QTL 284 (human) 1.95 0.0013 Body weight 15 21792889 47792889 Human 597222661 GWAS1318735_H aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1318735 (human) 2e-09 aspartate aminotransferase to alanine aminotransferase ratio serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) 15 40104990 40104991 Human 597265510 GWAS1361584_H triglyceride measurement QTL GWAS1361584 (human) 1e-11 triglyceride measurement blood triglyceride level (CMO:0000118) 15 40104990 40104991 Human
Data has come from the GWAS Catalog
The highlighted row represents the current QTL
GWAS1132162_H
GCST010244
Triglyceride levels
441,016 European ancestry individuals
C
0.804729
5E-10
9.302
rs34245505
0.015807
triglyceride measurement (EFO:0004530)
PMID:32203549
GWAS1156617_H
GCST007080
Lung function (FEV1/FVC)
approximately 370,000 European ancestry individuals
?
NR
5E-19
18.302
rs34245505
N/A
FEV/FVC ratio (EFO:0004713)
PMID:30595370
GWAS1661957_H
GCST90492734
Type 2 diabetes
50,251 African American cases, 103,909 African American controls, 88,109 East Asian ancestry cases, 339,395 East Asian ancestry controls, 242,283 European ancestry cases, 1,569,734 European ancestry controls, 29,375 Hispanic cases, 59,368 Hispanic controls, 1,602 South African ancestry cases, 976 South African ancestry controls, 16,832 South Asian ancestry cases, 33,767 South Asian ancestry controls
G
0.16393
3E-20
19.523
rs34245505
N/A
PMID:38374256
GWAS703291_H
GCST007429
Lung function (FVC)
321,047 European ancestry individuals
C
0.805
2E-12
11.699
rs34245505
0.0212
vital capacity (EFO:0004312)
PMID:30804560
GWAS753284_H
GCST007431
Lung function (FEV1/FVC)
321,047 European ancestry individuals
C
0.805
7E-13
12.155
rs34245505
0.0218
FEV/FVC ratio (EFO:0004713)
PMID:30804560
GWAS1318735_H
GCST90019498
Aspartate aminotransferase to alanine aminotransferase ratio
341,165 European ancestry individuals, 5,981 African ancestry individuals, 7,309 South Asian ancestry individuals
G
NR
2E-9
8.699
rs34245505
0.0183
aspartate aminotransferase to alanine aminotransferase ratio (EFO:0010934)
PMID:33462484
GWAS1361584_H
GCST90239664
Triglyceride levels
1,320,016 European ancestry individuals
G
0.187902
1E-11
11
rs34245505
0.0153228
triglyceride measurement (EFO:0004530)
PMID:34887591
GWAS1399066_H
GCST90020028
Hip circumference adjusted for BMI
219,872 British ancestry women
G
NR
4E-11
10.398
rs34245505
0.0236647
BMI-adjusted hip circumference (EFO:0008039)
PMID:34021172
GWAS1417665_H
GCST90244680
Triglyceride levels in non-type 2 diabetes
402,944 European ancestry individuals
?
NR
6E-10
9.222
rs34245505
N/A
triglyceride measurement (EFO:0004530)
PMID:36269708
GWAS1442440_H
GCST90244094
Lung function (FEV1/FVC)
475,645 European ancestry individuals, 8,590 African ancestry individuals, 85,279 East Asian ancestry individuals, 4,270 South Asian ancestry individuals, 14,668 Hispanic or Latin American individuals
C
0.816
1E-15
15
rs34245505
8.018
FEV/FVC ratio (EFO:0004713)
PMID:36914875